Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab. - Wikidata - wikimedia - TriplyDB

Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab.

Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab.

http://www.wikidata.org/entity/Q37703466

about

Tumor Necrosis Factor (TNF) Bioactivity at the Site of an Acute Cell-Mediated Immune Response Is Preserved in Rheumatoid Arthritis Patients Responding to Anti-TNF Therapy

P2860

Q38616681-0F43D040-0768-47C5-B71E-19510D624F50

P2860

Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab.

http://www.wikidata.org/entity/Q37703466

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Methotrexate Reduced TNF Bioac ...... ients Treated with Infliximab.

@en

Methotrexate Reduced TNF Bioac ...... ients Treated with Infliximab.

@nl

type

label

Methotrexate Reduced TNF Bioac ...... ients Treated with Infliximab.

@en

Methotrexate Reduced TNF Bioac ...... ients Treated with Infliximab.

@nl

prefLabel

Methotrexate Reduced TNF Bioac ...... ients Treated with Infliximab.

@en

Methotrexate Reduced TNF Bioac ...... ients Treated with Infliximab.

@nl

P1433

Q37703466-56F38563-DE30-45D1-9679-0C7DAFCE62FB

P1476

Q37703466-2224E1A1-F890-4D13-9527-00AE64EE35C7

P2093

Q37703466-357D346F-F3DB-48D4-9F1C-9AD5ABDF33DE

Q37703466-EA21F031-3B42-437E-8A9D-083C39F50F3E

P2860

Q37703466-107E37B2-5475-4CD3-8549-0874E5B80B18

Q37703466-12B6A74C-47BF-462C-BF2E-3F8A63E8F608

Q37703466-2A1A082E-8C37-4AFF-8ACB-6F9D215A5D7A

Q37703466-455C34AE-FD93-4B4A-930E-632CB15F00C0

Q37703466-51382385-3534-4194-827E-78A111167A46

Q37703466-5820648A-C7C1-45AE-83B1-C9EE5CCCF131

Q37703466-5A7DFB26-5498-4532-B18F-8467E1F1ECBE

Q37703466-5CD32876-0499-45FC-9C3C-193F02090636

Q37703466-7F7DB633-B45C-465E-BC69-4DB7A7D5528C

Q37703466-9F2AD04F-462D-4E58-8DAD-3C888BCDAA28

P304

Q37703466-6DA96A16-AC9F-4BA0-8B92-0C983210F4B4

P31

Q37703466-AC549760-2F8A-44D1-89EC-43D0E8EF79D0

P356

Q37703466-8CC687CE-2CAB-44C9-BF86-3F5A289ACB78

P478

Q37703466-624FAC35-01F5-462C-BF0B-2B7511447BFD

P50

Q37703466-70FF28D2-AB23-4ACF-8598-3C5AB97E8563

Q37703466-A2ADF6EA-86D3-4322-9C3B-EF6349D32CD2

Q37703466-D7D1B4F5-26F4-4287-87CE-BE4D40E7700B

P577

Q37703466-47F01A72-4281-4C4D-911B-11E2E427609C

P698

Q37703466-8825F0D6-F150-4CE9-A811-58B11CED84F6

P921

Q37703466-58F76B8C-0E04-48EF-B1ED-B62537F747AA

P932

Q37703466-9E89FB9E-1E69-49ED-B1EE-0CACF891CACC

P356

P1433

Mediators of Inflammation

P1476

Methotrexate Reduced TNF Bioac ...... ients Treated with Infliximab.

@en

P2093

Mélanie Rinaudo-Gaujous

http://www.w3.org/2001/XMLSchema#string

Thierry Thomas

http://www.w3.org/2001/XMLSchema#string

P2860

Circulating tumour necrosis factor-alpha bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritis.

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases

A personalized medicine approach to biologic treatment of rheumatoid arthritis: a preliminary treatment algorithm.

Autoantibody production in anti-TNF-alpha-treated patients.

Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review

Biomarkers for prediction of TNFalpha blockers response in rheumatoid arthritis.

Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective.

P304

3708250

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/3708250

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Delphine Dénarié

P577

2017-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28352145

http://www.w3.org/2001/XMLSchema#string

P921

P932

5352896

http://www.w3.org/2001/XMLSchema#string